The burgeoning development of nanomedicine has provided state-of-the-art technologies and innovative methodologies for contemporary biomedical research,presenting unprecedented opportunities for resolving pivotal biom...The burgeoning development of nanomedicine has provided state-of-the-art technologies and innovative methodologies for contemporary biomedical research,presenting unprecedented opportunities for resolving pivotal biomedical challenges.Nanomaterials possess distinctive structures and properties.Through the exploration of the fabrication of emerging nanomedicines,multiple functions can be integrated to enable more precise diagnosis and treatment,thereby compensating for the limitations of traditional treatment modalities.Among various substances,polyphenols are natural organic compounds classified as plant secondary metabolites and are ubiquitously present in vegetables,teas,and other plants.Polyphenols are rich in active groups,including hydroxyl,carboxyl,amino,and conjugated double bonds.They exhibit robust adhesion,antioxidant,anti-inflammatory,and antibacterial biological activities and are extensively applied in pharmaceutical formulations.Additionally,polyphenols are characterized by their low cost,ready availability,and do not necessitate intricate chemical synthesis processes.Nevertheless,when natural polyphenol-based nanomedicines are utilized in isolation,they encounter several issues.These include poor water solubility,feeble stability,low bioavailability,the requirement for high dosages,and difficulties in precisely reaching the site of action.To address these concerns,researchers have developed nanomedicines by combining metal ions and functional ligands through metal coordination strategies.Nanomaterials,owing to their unique electronic and optical properties,have been successfully introduced into the realm of medical biology.Nano preparations not only enhance the stability of natural products but also endow them with targeting capabilities,thus enabling precise drug delivery.Polyphenols can further synergize with metal ions,anti-cancer drugs,or photosensitizers via supramolecular interactions to achieve multifunctional synergistic therapies,such as targeted drug delivery,efficacy enhancement,and the construction of engineering scaffolds.Metal-Polyphenol Coordination Polymers(MPCPs),composed of metal ions and phenolic ligands,are regarded as ideal nanoplatforms for disease diagnosis and treatment.In recent years,MPCPs have attracted extensive research in the biomedical field on account of their advantages,including facile synthesis,adjustable structure,excellent biocompatibility,and pH responsiveness.In this review,the classification and preparation strategies of MPCPs were systematically presented.Subsequently,their remarkable achievements in biomedical domains,such as bioimaging,biosensing,drug delivery,tumor therapy,and antimicrobial applications were highlighted.Finally,the principal limitations and prospects of MPCPs were comprehensi vely discussed.展开更多
Dysregulation of polycomb group protein Bmi-1 expression has been linked with an invasive phenotype of certain human cancers and poor prognosis of patients; however, the underlying mechanisms are
文摘The burgeoning development of nanomedicine has provided state-of-the-art technologies and innovative methodologies for contemporary biomedical research,presenting unprecedented opportunities for resolving pivotal biomedical challenges.Nanomaterials possess distinctive structures and properties.Through the exploration of the fabrication of emerging nanomedicines,multiple functions can be integrated to enable more precise diagnosis and treatment,thereby compensating for the limitations of traditional treatment modalities.Among various substances,polyphenols are natural organic compounds classified as plant secondary metabolites and are ubiquitously present in vegetables,teas,and other plants.Polyphenols are rich in active groups,including hydroxyl,carboxyl,amino,and conjugated double bonds.They exhibit robust adhesion,antioxidant,anti-inflammatory,and antibacterial biological activities and are extensively applied in pharmaceutical formulations.Additionally,polyphenols are characterized by their low cost,ready availability,and do not necessitate intricate chemical synthesis processes.Nevertheless,when natural polyphenol-based nanomedicines are utilized in isolation,they encounter several issues.These include poor water solubility,feeble stability,low bioavailability,the requirement for high dosages,and difficulties in precisely reaching the site of action.To address these concerns,researchers have developed nanomedicines by combining metal ions and functional ligands through metal coordination strategies.Nanomaterials,owing to their unique electronic and optical properties,have been successfully introduced into the realm of medical biology.Nano preparations not only enhance the stability of natural products but also endow them with targeting capabilities,thus enabling precise drug delivery.Polyphenols can further synergize with metal ions,anti-cancer drugs,or photosensitizers via supramolecular interactions to achieve multifunctional synergistic therapies,such as targeted drug delivery,efficacy enhancement,and the construction of engineering scaffolds.Metal-Polyphenol Coordination Polymers(MPCPs),composed of metal ions and phenolic ligands,are regarded as ideal nanoplatforms for disease diagnosis and treatment.In recent years,MPCPs have attracted extensive research in the biomedical field on account of their advantages,including facile synthesis,adjustable structure,excellent biocompatibility,and pH responsiveness.In this review,the classification and preparation strategies of MPCPs were systematically presented.Subsequently,their remarkable achievements in biomedical domains,such as bioimaging,biosensing,drug delivery,tumor therapy,and antimicrobial applications were highlighted.Finally,the principal limitations and prospects of MPCPs were comprehensi vely discussed.
文摘Dysregulation of polycomb group protein Bmi-1 expression has been linked with an invasive phenotype of certain human cancers and poor prognosis of patients; however, the underlying mechanisms are
